Abstract:Coxsackievirus B3 (CVB3) is a non-enveloped, single-stranded, positive RNA virus known for its role in provoking inflammatory diseases that affect the heart, pancreas, and brain, leading to conditions such as myocarditis, pancreatitis, and meningitis. Currently, there are no FDA-approved drugs treating CVB3 infection; therefore, identifying potential molecular targets for antiviral drug development is imperative. In this study, we examined the possibility of activating the cyclic GMP-AMP (cGAMP) synthase (cGAS)-stimulator of interferon genes (STING) pathway, a cytosolic DNA-sensing pathway that triggers a type-I interferon (IFN) response, in inhibiting CVB3 infection. We found that activation of the cGAS-STING pathway through the application of cGAS (poly dA:dT and herring testes DNA) or STING agonists (2'3'-cGAMP and diamidobenzimidazole), or the overexpression of STING, significantly suppresses CVB3 replication. Conversely, gene-silencing of STING enhances viral replication. Mechanistically, we demonstrated that cGAS-STING activation combats CVB3 infection by inducing IFN response. Notably, we discovered that knockdown of IFN-α/β receptor, a key membrane receptor in type-I IFN signaling, or inhibition of the downstream JAK1/2 signaling with ruxolitinib, mitigates the effects of STING activation, resulting in increased viral protein production. Furthermore, we investigated the interplay between CVB3 and the cGAS-STING pathway. We showed that CVB3 does not trigger cGAS-STING activation; instead, it antagonizes STING and the downstream TBK1 activation induced by cGAMP. In summary, our results provide insights into the interaction of an RNA virus and the DNA-sensing pathway, highlighting the potential for agonist activation of the cGAS-STING pathway in the development of anti-CVB3 drugs.

Synthesis of c-di-GMP analogs modified by ganciclovir and biological activity to induce type Ⅰ interferon

Design, Synthesis and Biological Evaluation of (2′,5′ and 3′5′-Linked) cGAMP Analogs that Activate Stimulator of Interferon Genes (STING)

Arabinose- and xylose-modified analogs of 2',3'-cGAMP act as STING agonists

Discovery of Small Molecule Cyclic GMP-AMP Synthase Inhibitors.

Distinct Dynamical and Conformational Features of Human STING in Response to 2'3'-cGAMP and c-di-GMP.

Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING

Progress on the Synthesis and Activity of Cyclic Dinucleotides As Stimulator of Interferon Gene (STING) Agonists

Design and syntheses of a bimolecular STING agonist based on the covalent STING antagonist

Exploration of the Binding Mechanism of Cyclic Dinucleotide Analogs to Stimulating Factor Proteins and the Implications for Subsequent Analog Drug Design

Activation of cGAS-STING suppresses coxsackievirus replication via interferon-dependent signaling

Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway

Synthesis and biological evaluation of all possible inosine-mixed cyclic dinucleotides that activate different hSTING variants

Design and Synthesis of Novel c-di-GMP G-Quadruplex Inducers as Bacterial Biofilm Inhibitors

The Regulatory Network of Cyclic GMP-AMP Synthase-Stimulator of Interferon Genes Pathway in Viral Evasion

Cyclic Diguanylate Analogues: Facile Synthesis, STING Binding Mode and Anti-Tumor Immunity Delivered by Cytidinyl/cationic Lipid

Design, synthesis, and evaluation of thiazolecarboxamide derivatives as stimulator of interferon gene inhibitors

Innate Immune Activation by Cgmp-Amp Nanoparticles Leads to Potent and Long-Acting Antiretroviral Response Against HIV-1.

Synthesis of Original Cyclic Dinucleotide Analogues Using the Sulfo-click Reaction

Development of Human Cgas-Specific Small-Molecule Inhibitors for Repression of Dsdna-Triggered Interferon Expression

Design, Synthesis and Biological Evaluation of Gentiopicroside Derivatives As Potential Antiviral Inhibitors.

Structure of STING Bound to Cyclic Di-Gmp Reveals the Mechanism of Cyclic Dinucleotide Recognition by the Immune System